To the Editor The APPAC trial1 successfully recruited and randomized a large number of patients with uncomplicated appendicitis into surgical or antibiotic treatment groups. Even though the results support antibiotic treatment as a viable alternative to surgery for uncomplicated appendicitis, such a change in practice needs to be viewed in the context of the global increase in antimicrobial resistance.2